Thursday , November 14 2024
Home / Real-World Economics Review / How many times do the drug companies have to be paid for their research?

How many times do the drug companies have to be paid for their research?

Summary:
From Dean Baker That’s what readers of this Politico piece on efforts to restrict patent monopoly pricing of a coronavirus vaccine as a quid pro quo for government funding must be wondering. One might think that if the taxpayers put up money for the research then they have already paid for it, and therefore no patent monopolies would be involved. The vaccine would sell as a cheap generic and drug companies would make profits from it in the same way that manufacturers of paper clips and plastic cups make profits. But, that is far too simple for our Washington policy types. Even though the government puts up the research money, the government still has to grant the drug companies patent monopolies, and then beg them not to charge us too much money for the vaccines they developed with our

Topics:
Dean Baker considers the following as important:

This could be interesting, too:

Merijn T. Knibbe writes Argentina bucks the trend. Vitamin A deficiencies are increasing

John Quiggin writes Armistice Day

Editor writes Making America Great Again, 2024

Merijn T. Knibbe writes Völkermord in Gaza. Two million deaths are in the cards.

from Dean Baker

That’s what readers of this Politico piece on efforts to restrict patent monopoly pricing of a coronavirus vaccine as a quid pro quo for government funding must be wondering. One might think that if the taxpayers put up money for the research then they have already paid for it, and therefore no patent monopolies would be involved. The vaccine would sell as a cheap generic and drug companies would make profits from it in the same way that manufacturers of paper clips and plastic cups make profits.

But, that is far too simple for our Washington policy types. Even though the government puts up the research money, the government still has to grant the drug companies patent monopolies, and then beg them not to charge us too much money for the vaccines they developed with our money.

Too bad no one in Washington policy debates believes in the free market.

Dean Baker
Dean Baker is a macroeconomist and codirector of the Center for Economic and Policy Research in Washington, DC. He previously worked as a senior economist at the Economic Policy Institute and an assistant professor at Bucknell University. He is a regular Truthout columnist and a member of Truthout's Board of Advisers.

Leave a Reply

Your email address will not be published. Required fields are marked *